Live Breaking News & Updates on Analyst Recommendations For Crinetics Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for crinetics pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month price […] ....

Stephenf Betz , Robertw Baird , Piper Sandler , Marc Wilson , Cantor Fitzgerald , Securities Exchange Commission , News Ratings For Crinetics Pharmaceuticals Daily , Analyst Recommendations For Crinetics Pharmaceuticals , Crinetics Pharmaceuticals , Crinetics Pharmaceuticals Inc , Highmark Wealth Management , Crinetics Pharmaceuticals Price Performance , Morgan Stanley , Comerica Bank , Get Free Report , Exchange Commission , Mark Wealth Management , Amalgamated Bank , Get Free , Crinetics Pharmaceuticals Daily ,

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives $58.42 Consensus Price Target from Brokerages

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […] ....

Robertw Baird , Marc Wilson , Dana Pizzuti , News Ratings For Crinetics Pharmaceuticals Daily , Artal Group , Janus Henderson Group , Crinetics Pharmaceuticals Inc , Cantor Fitzgerald , Crinetics Pharmaceuticals , Jennison Associates , Analyst Recommendations For Crinetics Pharmaceuticals , Pricet Rowe Associates Inc , Institutional Investors Weigh In On Crinetics Pharmaceuticals , Morgan Stanley , Crinetics Pharmaceuticals Stock Performance , Securities Exchange Commission , Get Free Report , Exchange Commission , Henderson Group , Pricet Rowe Associates , Get Free , Crinetics Pharmaceuticals Daily ,

Robert W. Baird Boosts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $62.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target boosted by Robert W. Baird from $52.00 to $62.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts have also recently commented on CRNX. Oppenheimer raised their […] ....

United States , Stephenf Betz , Piper Sandler , Richard Scott Struthers , Robertw Baird , News Ratings For Crinetics Pharmaceuticals Daily , Victory Capital Management Inc , Analyst Recommendations For Crinetics Pharmaceuticals , Securities Exchange Commission , Crinetics Pharmaceuticals Stock Performance , Principal Financial Group Inc , Crinetics Pharmaceuticals Inc , Crinetics Pharmaceuticals , Mirae Asset Global Investments Co , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Scott Struthers , Asset Global Investments , Retirement System , Financial Group , Capital Management , Arizona State Retirement System , State Retirement System , Crinetics Pharmaceuticals Daily ,

Crinetics Pharmaceuticals' (CRNX) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $60.00 price target on the stock. A number of other equities analysts also recently weighed in on the company. JMP Securities reiterated a market […] ....

Stephenf Betz , Robertw Baird , Piper Sandler , Marc Wilson , Analyst Recommendations For Crinetics Pharmaceuticals , Alps Advisors Inc , Crinetics Pharmaceuticals Company Profile , News Ratings For Crinetics Pharmaceuticals Daily , Crinetics Pharmaceuticals Price Performance , Hennion Walsh Asset Management Inc , Comerica Bank , Securities Exchange Commission , Crinetics Pharmaceuticals , Cantor Fitzgerald , Crinetics Pharmaceuticals Inc , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Walsh Asset Management , Crinetics Pharmaceuticals Daily ,

Crinetics Pharmaceuticals (NASDAQ:CRNX) Given New $70.00 Price Target at Morgan Stanley

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target increased by Morgan Stanley from $50.00 to $70.00 in a research note released on Thursday, Benzinga reports. They currently have an overweight rating on the stock. Several other equities research analysts have also recently commented on CRNX. Jonestrading increased their price objective on Crinetics Pharmaceuticals […] ....

United States , Robertw Baird , Dana Pizzuti , Richard Scott Struthers , Analyst Recommendations For Crinetics Pharmaceuticals , Cantor Fitzgerald , Principal Financial Group Inc , Securities Exchange Commission , News Ratings For Crinetics Pharmaceuticals Daily , Morgan Stanley , Mirae Asset Global Investments Co , Crinetics Pharmaceuticals , Crinetics Pharmaceuticals Stock Performance , Victory Capital Management Inc , Crinetics Pharmaceuticals Inc , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Scott Struthers , Asset Global Investments , Retirement System , Financial Group , Capital Management , Arizona State Retirement System , State Retirement System ,